The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarstons Regulatory News (MARS)

Share Price Information for Marstons (MARS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 27.35
Bid: 27.15
Ask: 27.50
Change: 0.10 (0.37%)
Spread: 0.35 (1.289%)
Open: 27.20
High: 27.35
Low: 27.15
Prev. Close: 27.25
MARS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

25 May 2022 08:54

RNS Number : 7429M
Marston's PLC
25 May 2022
 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00B1JQDM80

Issuer Name

MARSTON'S PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of financial instruments

3. Details of person subject to the notification obligation

Name

Coltrane Asset Management, L.P.

City of registered office (if applicable)

 

Country of registered office (if applicable)

US

4. Details of the shareholder

Name

City of registered office

Country of registered office

Coltrane Master Fund, L.P

Grand Cayman

Cayman Islands

Coltrane Long Value Master Fund, L.P.

Grand Cayman

Cayman Islands

5. Date on which the threshold was crossed or reached

23-May-2022

6. Date on which Issuer notified

24-May-2022

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

0.000000

3.730000

3.730000

6970388

Position of previous notification (if applicable)

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

 

Sub Total 8.A

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

 

Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

Equity CFD

N/A

Cash

6970388

3.730000

Sub Total 8.B2

6970388

3.730000%

9. Information in relation to the person subject to the notification obligation

2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Coltrane Asset Management, L.P.

Mandeep Manku

Coltrane Domestic Fund, L.P.

Coltrane Offshore Fund, L.P.

Coltrane Asset Management Holdings, Ltd.

Coltrane GP, LLC

Coltrane Master Fund, L.P.

Coltrane Long Value Domestic Fund, L.P.

Coltrane Long Value Offshore Fund, Ltd.

Coltrane Long Value GP LLC

Coltrane Long Value Master Fund, L.P.

10. In case of proxy voting

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

11. Additional Information

Correction of a previous notification

12. Date of Completion

24-May-2022

13. Place Of Completion

New York, NY

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLFIFEDELIEFIF
Date   Source Headline
28th Nov 202212:55 pmRNSChange to Final Results date and update on trading
28th Nov 20229:59 amRNSHolding(s) in Company
25th Nov 202212:04 pmRNSHolding(s) in Company
17th Nov 20229:14 amRNSHolding(s) in Company
17th Nov 20227:09 amRNSDirector Declaration re: New Directorship
10th Nov 202210:47 amRNSHolding(s) in Company
9th Nov 20228:15 amRNSHolding(s) in Company
3rd Nov 20224:25 pmRNSHolding(s) in Company
3rd Nov 20223:05 pmRNSHolding(s) in Company
11th Oct 20227:00 amRNSTrading update for the 52 weeks to 1 October 2022
6th Oct 20229:31 amRNSCorrection re Holding(s) in Company
5th Oct 202212:15 pmRNSHolding(s) in Company
12th Sep 20229:43 amRNSDirector/PDMR Shareholding
5th Sep 202212:27 pmRNSDirector/PDMR Shareholding
2nd Sep 202210:14 amRNSDirector/PDMR Shareholding
31st Aug 20222:51 pmRNSHolding(s) in Company
27th Jul 20227:00 amRNSTrading update for the 42 weeks to 23 July 2022
11th Jul 202212:03 pmRNSBlock listing Interim Review
7th Jul 20229:55 amRNSHolding(s) in Company
29th Jun 20228:45 amRNSDirector/PDMR Shareholding
13th Jun 20228:30 amRNSDirector/PDMR Shareholding
30th May 20222:14 pmRNSHolding(s) in Company
25th May 20228:54 amRNSHolding(s) in Company
20th May 202210:15 amRNSDirector/PDMR Shareholding
19th May 20227:00 amRNSInvestor Meet Company Presentation
18th May 20227:00 amRNSRESULTS FOR THE 26 WEEKS ENDED 2 APRIL 2022
5th Apr 202212:39 pmRNSHolding(s) in Company
30th Mar 20228:28 amRNSDirector/PDMR Shareholding
28th Mar 20229:49 amRNSHolding(s) in Company
17th Mar 202210:18 amRNSHolding(s) in Company
8th Mar 202210:06 amRNSHolding(s) in Company
7th Mar 20227:00 amRNSDirectorate Change
3rd Mar 20229:45 amRNSHolding(s) in Company
18th Feb 20221:09 pmRNSHolding(s) in Company
25th Jan 20222:35 pmRNSTrading for the period to 22 Jan 2022 - Correction
25th Jan 20222:20 pmRNSResult of AGM
25th Jan 20227:00 amRNSTrading for the 16-week period to 22 January 2022
10th Jan 20223:55 pmRNSBlock listing Interim Review
20th Dec 20214:15 pmRNSAnnual Financial Report
7th Dec 202111:11 amRNSDirector/PDMR Shareholding
30th Nov 20217:00 amRNSRESULTS FOR THE 52 WEEKS ENDED 2 OCTOBER 2021
19th Oct 20219:05 amRNSHolding(s) in Company
13th Oct 20217:00 amRNSYear end trading update
30th Sep 202110:43 amRNSDisclosure of 2020/21 LTIP performance targets
16th Sep 20213:00 pmRNSDirector Declaration re: New Directorship
9th Sep 20212:30 pmRNSDirector/PDMR Shareholding
28th Jul 20217:00 amRNSTrading Update
20th Jul 20217:08 amRNSDirectorate Change
13th Jul 20218:36 amRNSBlock listing Interim Review
6th Jul 20217:00 amRNSAppointment of Chief Financial Officer

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.